SCHEDULE 13G/A: Invesco Ltd. Discloses Minimal 0.0% Stake in Rigel Pharmaceuticals
Beneficial Ownership Disclosure
Invesco Ltd. has filed an amended Schedule 13G, reporting a 0.0% beneficial ownership stake in Rigel Pharmaceuticals Inc. as of December 31, 2024.
Summary
- Invesco Ltd. filed an Amendment No. 1 to Schedule 13G concerning its beneficial ownership in Rigel Pharmaceuticals Inc.
- As of December 31, 2024, Invesco Ltd. beneficially owned an aggregate of 6,449 shares of Rigel Pharmaceuticals Inc. Common Stock.
- This ownership represents 0.0% of the total class of securities.
- Invesco Ltd. holds sole voting power over 5,861 shares and sole dispositive power over 6,449 shares.
- The filing classifies Invesco Ltd. as a parent holding company (HC) and an investment adviser (IA).
- The shares are held of record by clients of Invesco Ltd., and no single individual client has greater than 5% economic ownership.
Sentiment
Score: 5
Explanation: The filing is a routine disclosure of beneficial ownership and does not contain information that would significantly alter the perception of the issuer's financial health or prospects. The reported stake is immaterial.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of an institutional investor's beneficial ownership and does not provide specific insights into broader industry trends or competitive dynamics for Rigel Pharmaceuticals.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement |
| 02/06/2025 | Date of signature for the filing by Robert R. Leveille, Global Head of Compliance for Invesco Ltd. |
Keywords
Rigel Pharmaceuticals, Invesco Ltd., Schedule 13G, beneficial ownership, common stock, SEC filing, institutional ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.